A review on Advancements in Nanoparticles Based Pulmonary Drug Delivery

Abstract

Nanoparticles have emerged as a promising approach for pulmonary drug delivery, offering enhanced drug solubility, targeted delivery, and improved therapeutic efficacy. This abstract reviews the recent advancements in the field of nanoparticle-based pulmonary drug delivery. It discusses the various types of nanoparticles, including polymeric, lipid-based, and inorganic, and their potential applications in the treatment of respiratory diseases. The review also highlights the advantages of nanoparticles over conventional drug delivery methods, such as improved bioavailability, reduced side effects, and enhanced patient compliance. Furthermore, it examines the challenges and considerations in the development and clinical translation of nanoparticle-based pulmonary therapeutics. The abstract concludes by outlining future research directions and the significance of continued innovation in this field for improving patient outcomes.